Swiss Life Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.81M | Sell |
|
|||||
|
2025
Q2 | $7.76M | Buy |
|
|||||
|
2025
Q1 | $2.65M | Sell |
|
|||||
|
2024
Q4 | $3.01M | Buy |
|
|||||
|
2024
Q3 | $995K | Buy |
|
|||||
|
2024
Q2 | $474K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $654K | Sell |
|
|||||
|
2023
Q3 | $741K | Sell |
|
|||||
|
2023
Q2 | $821K | Sell |
|
|||||
|
2023
Q1 | $870K | Buy |
|
|||||
|
2022
Q4 | $953K | Buy |
|
|||||
|
2022
Q3 | $352K | Sell |
|
|||||
|
2022
Q2 | $273K | Buy |
|